Troubled US biotech Aeterna Zentaris has called in outside help to assist with a strategic review after a disastrous few months that saw the company axe its CEO, David Dodd.
US biotech OPKO Health has said it will continue with clinical development of its long-acting human growth hormone product (hGH-CTP), even though it has failed in a late stage trial in adul